Study of B7-H3, EGFR806, HER2, And IL13-Zetakine (Quad) CAR T Cell Locoregional Immunotherapy For Pediatric Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, And Recurrent Or Refractory Central Nervous System Tumors

SC-CAR4BRAIN - Seattle Children's Hospital

EGFR806-specific CAR T-cell therapy - Cellevolve Bio, Seattle Children’s Therapeutics

http://clinicaltrials.gov/ct2/show/NCT05768880

Jun 12, 2023